[HTML][HTML] Gut microbiota and its metabolites: bridge of dietary nutrients and Alzheimer's disease
G Zhu, J Zhao, H Zhang, G Wang, W Chen - Advances in Nutrition, 2023 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive
cognitive impairment and neuroinflammation. Recent research has revealed the crucial role …
cognitive impairment and neuroinflammation. Recent research has revealed the crucial role …
[HTML][HTML] Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European …
Background The risk of dementia is higher in women than men. The metabolic
consequences of estrogen decline during menopause accelerate neuropathology in …
consequences of estrogen decline during menopause accelerate neuropathology in …
[HTML][HTML] Specialized pro-resolving mediators in neuroinflammation: Overview of studies and perspectives of clinical applications
M Valente, M Dentoni, F Bellizzi, F Kuris, GL Gigli - Molecules, 2022 - mdpi.com
Specialized pro-resolving mediators (SPMs) are lipid mediators derived from poly-
unsaturated fatty acids (PUFAs) which have been demonstrated to have an important role in …
unsaturated fatty acids (PUFAs) which have been demonstrated to have an important role in …
[HTML][HTML] Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group
HN Yassine, C Samieri, G Livingston… - The Lancet Healthy …, 2022 - thelancet.com
Observational studies suggest that nutritional factors have a potential cognitive benefit.
However, systematic reviews of randomised trials of dietary and nutritional supplements …
However, systematic reviews of randomised trials of dietary and nutritional supplements …
Can nutrition support healthy cognitive ageing and reduce dementia risk?
A Jennings, SC Cunnane, AM Minihane - bmj, 2020 - bmj.com
Can nutrition support healthy cognitive ageing and reduce dementia risk? Page 1 the bmj | BMJ
2020;369:m2269 | doi: 10.1136/bmj.m2269 1 Food For ThoughT 2020 Can nutrition support …
2020;369:m2269 | doi: 10.1136/bmj.m2269 1 Food For ThoughT 2020 Can nutrition support …
Effect of APOE genotype on plasma docosahexaenoic acid (DHA), eicosapentaenoic acid, arachidonic acid, and hippocampal volume in the Alzheimer's disease …
N Tomaszewski, X He, V Solomon… - Journal of …, 2020 - content.iospress.com
Background: Docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and arachidonic
acid (AA) play key roles in several metabolic processes relevant to Alzheimer's disease (AD) …
acid (AA) play key roles in several metabolic processes relevant to Alzheimer's disease (AD) …
APOE4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in APOE‐TR mice
MG Pontifex, A Martinsen, RNM Saleh… - The FASEB …, 2021 - Wiley Online Library
The impact of sex and menopausal status in Alzheimer's disease remains understudied
despite increasing evidence of greater female risk, particularly in APOE4 carriers. Utilizing …
despite increasing evidence of greater female risk, particularly in APOE4 carriers. Utilizing …
[HTML][HTML] Therapeutic opportunities for food supplements in neurodegenerative disease and depression
Emerging evidence is showing nutrition as a crucial factor in the high prevalence and
incidence of neurodegenerative mental disorders. Preventive interventions on …
incidence of neurodegenerative mental disorders. Preventive interventions on …
Fish, n-3 fatty acids, cognition and dementia risk: not just a fishy tale
RNM Saleh, AM Minihane - Proceedings of the Nutrition Society, 2022 - cambridge.org
With growing and ageing populations, the incidence of dementia is expected to triple
globally by 2050. In the absence of effective drugs to treat or reverse the syndrome, dietary …
globally by 2050. In the absence of effective drugs to treat or reverse the syndrome, dietary …
[HTML][HTML] Alzheimer's disease and specialized pro-resolving lipid mediators: Do MaR1, RvD1, and NPD1 show promise for prevention and treatment?
K Miyazawa, H Fukunaga, Y Tatewaki… - International Journal of …, 2020 - mdpi.com
Alzheimer's disease (AD) is a common neurodegenerative disease and a major contributor
to progressive cognitive impairment in an aging society. As the pathophysiology of AD …
to progressive cognitive impairment in an aging society. As the pathophysiology of AD …